Hydronephrosis Caused by Metastatic Breast Cancer

• Published in: Case reports in oncology Vol. 14; no. 1; pp. 378 - 385
• Main Authors: Sugimoto, Hitoshi, Oda, Goshi, Yokoyama, Minato, Hayashi, Kumiko, Yoshino, Maho, Ogawa, Ayumi, Hosoya, Tokuko, Nakagawa, Tsuyoshi, Uetake, Hiroyuki
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2021; Karger Publishers
• Subjects: Back pain; Bladder; Breast cancer; Cancer surgery; Cancer therapies; Case Report; Case reports; Chemotherapy; Hydronephrosis; Lymphatic system; Medical prognosis; Metastasis; Patients; Stents; Breast cancer; Metastasis; Hydronephrosis
• ISSN: 1662-6575; 1662-6575
• DOI: 10.1159/000513903

Breast cancer metastasizes mainly to organs such as bone, lung, and liver, whereas metastases to the peritoneum and urinary tract are rare. Metastasis to the peritoneum or urinary tract may result in renal dysfunction, infection, and painful hydronephrosis. In our hospital, 1,409 breast cancer surgeries were performed between January 2004 and December 2015, and 7 cases of hydronephrosis associated with recurrence were observed. The median age of patients was 69 years (57–79 years). The median time from surgery to diagnosis of hydronephrosis was 47 months (20–70 months). Histology was invasive ductal carcinoma (IDC) in 6 cases and invasive lobular carcinoma (ILC) in 1 case. There were 6 bilateral cases and 1 unilateral case of hydronephrosis. The causes were retroperitoneal metastasis in 5 cases and lymph node metastasis in 2 cases. The hydronephrosis was untreated in 2 cases, and treated with a ureteral stent in 2 cases, nephrostomy in 1 case, and nephrostomy due to ureteral stent failure in 2 cases. The median survival from the onset of hydronephrosis was 12 months (3–57 months). Although the probability of hydronephrosis in breast cancer recurrence was not high, care must be taken to avoid renal dysfunction, infection, or pain, which may require treatment.